(Q37996299)

26 August 2017

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies (English)

1 reference

26 August 2017

Acinetobacter baumannii

1 reference

based on heuristic

inferred from title

antimicrobial resistance

1 reference

4

Beibei Liang

1 reference

26 August 2017

Yun Cai

1

1 reference

26 August 2017

Dong Chai

series ordinal

2

1 reference

26 August 2017

Rui Wang

series ordinal

3

1 reference

26 August 2017

Nan Bai

series ordinal

5

1 reference

26 August 2017

language of work or name

English

0 references

publication date

22 March 2012

1 reference

Journal of Antimicrobial Chemotherapy

26 August 2017

1 reference

26 August 2017

67

1 reference

26 August 2017

1607-1615

1 reference

26 August 2017

7

1 reference

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

26 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Colistin heteroresistance in acinetobacter and its association with previous colistin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Acinetobacter baumannii Resistant to Colistin With Impaired Virulence: A Case Report From France

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Susceptibility of 228 non-fermenting gram-negative rods to tigecycline and six other antimicrobial drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Genotypic diversity and antibiotic susceptibility of Acinetobacter baumannii isolates in a Bulgarian hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

[In vitro antimicrobial synergy against imipenem-resistant Acinetobacter baumannii].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Extensively drug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Prevalence of multidrug-resistant organisms recovered at a military burn center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Dissemination of IMP-1 metallo- beta -lactamase-producing Acinetobacter species in a Brazilian teaching hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Lipopolysaccharide endotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Amikacin and colistin for treatment of Acinetobacter baumannii meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS084

21 January 2018

Identifiers

DOI

10.1093/JAC/DKS084

1 reference

26 August 2017

1 reference